MX9308025A - Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. - Google Patents
Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.Info
- Publication number
- MX9308025A MX9308025A MX9308025A MX9308025A MX9308025A MX 9308025 A MX9308025 A MX 9308025A MX 9308025 A MX9308025 A MX 9308025A MX 9308025 A MX9308025 A MX 9308025A MX 9308025 A MX9308025 A MX 9308025A
- Authority
- MX
- Mexico
- Prior art keywords
- supreparation
- procedure
- pharmaceutical formulation
- immunodeficiency virus
- human immunodeficiency
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente invención proporciona nuevos inhibidores de proteasa de HIV, formulaciones farmacéuticas que contienen estos compuestos y procedimientos de tratamiento y/o prevención de infección por HIV y/o Sida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99562192A | 1992-12-22 | 1992-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9308025A true MX9308025A (es) | 1994-08-31 |
Family
ID=25542022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9308025A MX9308025A (es) | 1992-12-22 | 1993-12-15 | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0609625A1 (es) |
JP (1) | JPH06256277A (es) |
KR (1) | KR940014336A (es) |
CN (1) | CN1092410A (es) |
AU (1) | AU5252993A (es) |
BR (1) | BR9305161A (es) |
CA (1) | CA2112052A1 (es) |
CO (1) | CO4180513A1 (es) |
CZ (1) | CZ281393A3 (es) |
FI (1) | FI935780A (es) |
HU (1) | HUT69703A (es) |
IL (1) | IL108098A0 (es) |
MX (1) | MX9308025A (es) |
NO (1) | NO934721L (es) |
PL (1) | PL301578A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5747540A (en) * | 1996-10-21 | 1998-05-05 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
ATE343562T1 (de) | 2000-03-23 | 2006-11-15 | Elan Pharm Inc | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
YU23503A (sh) * | 2000-09-29 | 2006-03-03 | Neurogen Corporation | Mali molekuli kao modulatori receptora c5a visokog afiniteta |
EP1406898B1 (en) * | 2001-07-19 | 2005-04-06 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
WO2003029169A2 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
WO2004058686A1 (en) | 2002-04-30 | 2004-07-15 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer’s disease |
JP4721214B2 (ja) * | 2004-09-14 | 2011-07-13 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法 |
JP4698991B2 (ja) * | 2004-09-14 | 2011-06-08 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法 |
JP2008535863A (ja) | 2005-04-08 | 2008-09-04 | コメンティス,インコーポレーテッド | β−セクレターゼ活性を阻害する化合物およびその使用方法 |
US8791135B2 (en) * | 2008-07-01 | 2014-07-29 | Purdue Research Foundation | Nonpeptide HIV-1 protease inhibitors |
CN110872251A (zh) * | 2019-11-28 | 2020-03-10 | 卡博金艾美斯医药(上海)有限公司 | N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
-
1993
- 1993-12-15 MX MX9308025A patent/MX9308025A/es unknown
- 1993-12-17 CZ CZ932813A patent/CZ281393A3/cs unknown
- 1993-12-20 NO NO934721A patent/NO934721L/no unknown
- 1993-12-20 HU HU9303677A patent/HUT69703A/hu unknown
- 1993-12-20 PL PL93301578A patent/PL301578A1/xx unknown
- 1993-12-20 AU AU52529/93A patent/AU5252993A/en not_active Abandoned
- 1993-12-20 IL IL10809893A patent/IL108098A0/xx unknown
- 1993-12-20 EP EP93310355A patent/EP0609625A1/en not_active Withdrawn
- 1993-12-20 CO CO93423578A patent/CO4180513A1/es unknown
- 1993-12-21 CN CN93112960A patent/CN1092410A/zh active Pending
- 1993-12-21 JP JP5321876A patent/JPH06256277A/ja not_active Withdrawn
- 1993-12-21 BR BR9305161A patent/BR9305161A/pt not_active Application Discontinuation
- 1993-12-21 FI FI935780A patent/FI935780A/fi not_active Application Discontinuation
- 1993-12-21 CA CA002112052A patent/CA2112052A1/en not_active Abandoned
- 1993-12-22 KR KR1019930029120A patent/KR940014336A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0609625A1 (en) | 1994-08-10 |
NO934721D0 (no) | 1993-12-20 |
NO934721L (no) | 1994-06-23 |
IL108098A0 (en) | 1994-04-12 |
CN1092410A (zh) | 1994-09-21 |
PL301578A1 (en) | 1994-06-27 |
CO4180513A1 (es) | 1995-06-07 |
JPH06256277A (ja) | 1994-09-13 |
KR940014336A (ko) | 1994-07-18 |
AU5252993A (en) | 1994-07-07 |
HUT69703A (en) | 1995-09-28 |
BR9305161A (pt) | 1994-11-01 |
CZ281393A3 (en) | 1994-07-13 |
FI935780A0 (fi) | 1993-12-21 |
HU9303677D0 (en) | 1994-04-28 |
FI935780A (fi) | 1994-06-23 |
CA2112052A1 (en) | 1994-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9308005A (es) | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. | |
MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
ES2150933T3 (es) | Inhibidores de la proteasa vih utiles para el tratamiento del sida. | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
MX9308025A (es) | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. | |
ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
BG100455A (en) | Hiv protease inhibitors | |
UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
ES2125251T3 (es) | Inhibidores de la proteasa del vih. | |
ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
DE69830751D1 (de) | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen | |
LV12719A (lv) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
PT705100E (pt) | Guanidinas substituidas terapeuticas | |
MX9203972A (es) | Compuestos inhibidores de la proteasa codificada por el virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulado farmaceutico que los contiene. | |
ES2183817T3 (es) | Inibidores de proteasas de parasatiso metazoarios. | |
MX9303572A (es) | Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. | |
EP0594795A4 (en) | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT. | |
ATE245444T1 (de) | Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen | |
MX9302681A (es) | Nuevas quinazolinas como inhibidores de transcriptasa inversa hiv. | |
ES2096874T3 (es) | Inhibidor de la proteasa de hiv util para el tratamiento del sida. | |
ES2159287T3 (es) | Peptidos hemorreguladores. | |
MX9306607A (es) | Dindihidrogeno-otorfosfato de tilidina, procedimiento para su obtencion y las preparaciones farmaceuticas que lo contienen. | |
NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
UA41338C2 (uk) | Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл) |